Harbour Capital Advisors LLC Has $2.23 Million Position in UnitedHealth Group Incorporated (UNH)
Harbour Capital Advisors LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,616 shares of the healthcare conglomerate’s stock after buying an additional 370 shares during the period. UnitedHealth Group accounts for about 1.0% of Harbour Capital Advisors LLC’s holdings, making the stock its 15th largest position. Harbour Capital Advisors LLC’s holdings in UnitedHealth Group were worth $2,233,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the stock. State Street Corp raised its stake in UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after buying an additional 1,122,534 shares during the last quarter. Ameriprise Financial Inc. raised its stake in UnitedHealth Group by 29.9% in the first quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock valued at $546,574,000 after buying an additional 766,573 shares during the last quarter. Swiss National Bank raised its stake in UnitedHealth Group by 25.8% in the first quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock valued at $610,033,000 after buying an additional 763,161 shares during the last quarter. Karp Capital Management Corp bought a new stake in UnitedHealth Group during the first quarter valued at about $113,729,000. Finally, Old Mutual Global Investors UK Ltd. bought a new stake in UnitedHealth Group during the first quarter valued at about $109,807,000. 86.37% of the stock is owned by institutional investors and hedge funds.
Shares of UnitedHealth Group Incorporated (UNH) traded up 0.23% during mid-day trading on Friday, reaching $193.02. The company’s stock had a trading volume of 2,210,720 shares. The stock has a market cap of $186.62 billion, a P/E ratio of 23.19 and a beta of 0.64. The stock has a 50 day moving average of $189.36 and a 200-day moving average of $174.75. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.04.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the prior year, the company earned $1.96 earnings per share. The company’s revenue was up 7.7% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
Several equities research analysts have recently issued reports on UNH shares. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, May 19th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $187.00 price objective (up from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Mizuho raised their price objective on UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a research note on Tuesday, April 18th. Vetr upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price target on the stock in a report on Tuesday, May 30th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $208.00 price target on shares of UnitedHealth Group in a report on Friday, July 21st. One analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $202.20.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares in the company, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold 15,540 shares of company stock worth $2,873,320 in the last ninety days. Corporate insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.